The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in MiceYasushi Honda, Atsushi Nakajima|PLoS ONE|2016Cited by 169
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitisYasushi Honda, Atsushi Nakajima|Scientific Reports|2017Cited by 128